HQY
Income statement / Annual
Last year (2024), HealthEquity, Inc.'s total revenue was $999.59 M,
an increase of 16.00% from the previous year.
In 2024, HealthEquity, Inc.'s net income was $55.71 M.
See HealthEquity, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
01/31/2024 |
01/31/2023 |
01/31/2022 |
01/31/2021 |
01/31/2020 |
01/31/2019 |
01/31/2018 |
01/31/2017 |
01/31/2016 |
01/31/2015 |
Operating Revenue |
$999.59 M
|
$861.75 M
|
$756.56 M
|
$733.57 M
|
$531.99 M
|
$287.24 M
|
$229.53 M
|
$178.37 M
|
$126.79 M
|
$87.86 M
|
Cost of Revenue |
$376.95 M |
$371.66 M |
$332.85 M |
$318.24 M |
$206.08 M |
$106.05 M |
$94.61 M |
$72.02 M |
$54.19 M |
$39.88 M |
Gross Profit |
$622.64 M |
$490.09 M |
$423.71 M |
$415.33 M |
$325.91 M |
$181.19 M |
$134.92 M |
$106.36 M |
$72.60 M |
$47.97 M |
Gross Profit Ratio |
0.62 |
0.57 |
0.56 |
0.57 |
0.61 |
0.63 |
0.59 |
0.6 |
0.57 |
0.55 |
Research and Development
Expenses |
$218.81 M
|
$193.38 M
|
$157.36 M
|
$124.81 M
|
$77.58 M
|
$35.06 M
|
$27.39 M
|
$22.38 M
|
$16.83 M
|
$10.50 M
|
General & Administrative
Expenses |
$103.66 M
|
$95.63 M
|
$84.38 M
|
$84.49 M
|
$60.56 M
|
$33.04 M
|
$25.11 M
|
$20.15 M
|
$14.11 M
|
$8.34 M
|
Selling & Marketing
Expenses |
$79.27 M
|
$68.85 M
|
$58.61 M
|
$49.96 M
|
$43.95 M
|
$29.50 M
|
$23.14 M
|
$18.32 M
|
$13.30 M
|
$10.62 M
|
Selling, General &
Administrative Expenses |
$182.93 M
|
$164.48 M
|
$142.98 M
|
$134.46 M
|
$104.51 M
|
$62.54 M
|
$48.25 M
|
$38.47 M
|
$27.42 M
|
$18.96 M
|
Other Expenses |
$0.00 |
$94.59 M |
$82.79 M |
$76.06 M |
$34.70 M |
-$1.85 M |
-$2.23 M |
-$1.09 M |
-$589,000.00 |
-$374,000.00 |
Operating Expenses |
$401.74 M |
$452.44 M |
$383.14 M |
$335.33 M |
$216.79 M |
$103.52 M |
$80.50 M |
$65.14 M |
$46.46 M |
$31.10 M |
Cost And Expenses |
$871.45 M |
$824.10 M |
$715.99 M |
$653.57 M |
$422.88 M |
$209.57 M |
$175.11 M |
$137.16 M |
$100.64 M |
$70.98 M |
Interest Income |
$12.14 M |
$1.76 M |
$1.50 M |
$1.05 M |
$5.91 M |
$1.68 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$55.46 M |
$48.42 M |
$36.57 M |
$34.88 M |
$24.77 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$153.08 M
|
$161.20 M
|
$137.19 M
|
$115.90 M
|
$55.35 M
|
$18.19 M
|
$15.95 M
|
$13.19 M
|
$8.60 M
|
$1.64 M
|
EBITDA |
$282.42 M
|
$171.53 M
|
$102.97 M
|
$154.93 M
|
$123.28 M
|
$94.00 M
|
$68.14 M
|
$54.40 M
|
$34.74 M
|
$22.76 M
|
EBITDA Ratio |
0.28 |
0.23 |
0.23 |
0.27 |
0.29 |
0.33 |
0.31 |
0.3 |
0.27 |
0.21 |
Operating Income Ratio
|
0.13
|
0.05
|
0.05
|
0.11
|
0.14
|
0.27
|
0.24
|
0.23
|
0.21
|
0.19
|
Total Other
Income/Expenses Net |
-$53.09 M
|
-$47.15 M
|
-$42.50 M
|
-$29.87 M
|
-$33.85 M
|
-$1.85 M
|
-$2.23 M
|
-$1.09 M
|
-$589,000.00
|
-$1.11 M
|
Income Before Tax |
$75.04 M |
-$38.10 M |
-$66.74 M |
$4.14 M |
$43.16 M |
$75.82 M |
$52.19 M |
$40.12 M |
$25.55 M |
$15.76 M |
Income Before Tax Ratio
|
0.08
|
-0.04
|
-0.09
|
0.01
|
0.08
|
0.26
|
0.23
|
0.22
|
0.2
|
0.18
|
Income Tax Expense |
$19.33 M |
-$11.95 M |
-$22.45 M |
-$4.69 M |
$3.49 M |
$1.92 M |
$4.83 M |
$13.74 M |
$8.94 M |
$5.60 M |
Net Income |
$55.71 M |
-$26.14 M |
-$44.29 M |
$8.83 M |
$39.66 M |
$73.90 M |
$47.36 M |
$26.38 M |
$16.61 M |
$10.17 M |
Net Income Ratio |
0.06 |
-0.03 |
-0.06 |
0.01 |
0.07 |
0.26 |
0.21 |
0.15 |
0.13 |
0.12 |
EPS |
0.65 |
-0.31 |
-0.53 |
0.12 |
0.59 |
1.2 |
0.79 |
0.45 |
0.29 |
0.39 |
EPS Diluted |
0.64 |
-0.31 |
-0.53 |
0.12 |
0.58 |
1.17 |
0.77 |
0.44 |
0.28 |
0.21 |
Weighted Average Shares
Out |
$85.56 M
|
$84.44 M
|
$83.13 M
|
$74.24 M
|
$67.03 M
|
$61.84 M
|
$60.30 M
|
$58.62 M
|
$56.72 M
|
$31.18 M
|
Weighted Average Shares
Out Diluted |
$86.96 M
|
$84.44 M
|
$83.13 M
|
$75.68 M
|
$68.45 M
|
$63.37 M
|
$61.85 M
|
$59.89 M
|
$58.86 M
|
$51.86 M
|
Link |
|
|
|
|
|
|
|
|
|
|